(Q37756954)

22 August 2017

1 reference

title

Functional food ingredients as adjunctive therapies to pharmacotherapy for treating disorders of metabolic syndrome (English)

1 reference

22 August 2017

0 references

0 references

1 reference

Christopher P F Marinangeli

series ordinal

1

1 reference

PubMed ID

20486826

22 August 2017

Peter J H Jones

series ordinal

2

1 reference

PubMed ID

20486826

22 August 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

22 August 2017

1 reference

22 August 2017

42

1 reference

22 August 2017

5

1 reference

22 August 2017

317-333

1 reference

Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia

22 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Antioxidant paraoxonase 1 activity in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Oxidative stress and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Haemostatic function and platelet polyunsaturated fatty acids in Eskimos

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Suppression of hepatocyte nuclear factor-4alpha by acyl-CoA thioesters of hypolipidemic peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Effects of simvastatin on plasma antioxidant status and vitamins in hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Effects of low doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol levels in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Dose-response effects of atorvastatin and simvastatin on high-density lipoprotein cholesterol in hypercholesterolaemic patients: a review of five comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Effect of atorvastatin on lipid parameters, LDL subtype distribution, hemorrheological parameters and adhesion molecule concentrations in patients with hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Redox molecules and cancer prevention: the importance of understanding the role of the antioxidant network.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Chronic inflammation and oxidative stress in human carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

The opposing effects of n-3 and n-6 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Omega 3 fatty acids induce a marked reduction of apolipoprotein B48 when added to fluvastatin in patients with type 2 diabetes and mixed hyperlipidemia: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Adiponectin stimulates production of nitric oxide in vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Globular adiponectin upregulates nitric oxide production in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Plant sterols: factors affecting their efficacy and safety as functional food ingredients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Phytostanol tablets reduce human LDL-cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Plant sterols combined with exercise for the treatment of hypercholesterolemia: overview of independent and synergistic mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Gastrointestinal absorption and plasma kinetics of soy Delta(5)-phytosterols and phytostanols in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Plant sterols and stanols: effects on mixed micellar composition and LXR (target gene) activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Increased intestinal ABCA1 expression contributes to the decrease in cholesterol absorption after plant stanol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

The role of chemokines in human cardiovascular pathology: enhanced biological insights

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

beta-Sitosterol modulation of monocyte-endothelial cell interaction: a comparison to female hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Effects of a stanol-enriched diet on plasma cholesterol and triglycerides in patients treated with statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Non-cholesterol sterols in serum, lipoproteins, and red cells in statin-treated FH subjects off and on plant stanol and sterol ester spreads

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Phytosterols dissolved in diacylglycerol oil reinforce the cholesterol-lowering effect of low-dose pravastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Plant sterol-enriched margarine lowers plasma LDL in hyperlipidemic subjects with low cholesterol intake: effect of fibrate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Insulin resistance and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Insulin resistance, hyperinsulinemia, and cardiovascular disease. The need for novel dietary prevention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

No evidence of insulin resistance in normal weight vegetarians. A case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Dietary glycemic index, glycemic load, fiber, simple sugars, and insulin resistance: the Inter99 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

The consumption of bread enriched with betaglucan reduces LDL-cholesterol and improves insulin resistance in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Improvement of insulin resistance after diet with a whole-grain based dietary product: results of a randomized, controlled cross-over study in obese subjects with elevated fasting blood glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

A dietary exchange of common bread for tailored bread of low glycaemic index and rich in dietary fibre improved insulin economy in young women with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)-beta-glycan consumption in overweight humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Glucose and insulin responses to whole grain breakfasts varying in soluble fiber, beta-glucan: a dose response study in obese women with increased risk for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

AMP-activated protein kinase: Role in metabolism and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Erythrocyte insulin receptor tyrosine kinase activity is increased in glyburide-treated patients with type 2 diabetes in good glycaemic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Activation of AMP-activated protein kinase, inhibition of pyruvate dehydrogenase activity, and redistribution of substrate partitioning mediate the acute insulin-sensitizing effects of troglitazone in skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Pioglitazone reduces tumor necrosis factor-alpha serum concentration and mRNA expression of adipose tissue in hypercholesterolemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Effects of ghrelin on the proliferation and differentiation of 3T3-L1 preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Adipocyte size predicts incidence of type 2 diabetes in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Soluble dietary fibre improves insulin sensitivity by increasing muscle GLUT-4 content in stroke-prone spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Butyrate improves insulin sensitivity and increases energy expenditure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Inverse association between carotid intima-media thickness and the antioxidant lycopene in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Lycopene as the most efficient biological carotenoid singlet oxygen quencher

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Effect of lycopene from tomatoes (cooked) on plasma antioxidant enzymes, lipid peroxidation rate and lipid profile in grade-I hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Estimated phytochemical content of the dietary approaches to stop hypertension (DASH) diet is higher than in the Control Study Diet

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Effective prevention and treatment of Helicobacter pylori infection using a combination of catechins and sialic acid in AGS cells and BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Herb-drug interactions: an overview of the clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Effects of yoghurt enriched with plant sterols on serum lipids in patients with moderate hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Targeting Reactive Oxygen Species in Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Protective Effect of Dietary Tomato against Endothelial Dysfunction in Hypercholesterolemic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

Statins enhance circulating vitamin E

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.484026

10.3109/07853890.2010.484026

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20486826